Michael Egholm, President, Bio Pharmaceuticals at PALL CORP (PLL), sold 15,538 shares at $124.55 ($1.9M) on 2015-06-29, disclosed to the SEC on 2015-06-30.
Open-market sale of $1.9M PLL by President, Bio Pharmaceuticals. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $124.55 | 2,407 | $300K | 15.5% |
| 2 | $124.55 | 4,984 | $621K | 32.1% |
| 3 | $124.55 | 8,147 | $1.0M | 52.4% |
| Total | $124.55 avg | 15,538 | $1.9M | 100% |
| Filing → |
| LAB | SELL | 2025-05-22 | $5K | — | Filing → |
| PLL | SELL | 2014-12-23 | $762K | — | Filing → |
| PLL | SELL | 2014-07-16 | $211K | — | Filing → |